Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of zonisamide (CI-912) on a synaptic system model.

G H Fromm1, T Shibuya, C F Terrence

  • 1Department of Neurology, University of Pittsburgh School of Medicine, Pennsylvania 15261.

Epilepsia
|November 1, 1987
PubMed
Summary

Zonisamide (ZNS), an experimental antiepileptic drug, effectively treats various seizure types by modulating excitatory and inhibitory mechanisms. Its broad-spectrum activity profile in cats predicts clinical efficacy, similar to valproate.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients with epilepsy who die suddenly have cardiac disease.

Archives of neurology·1998
Same author

Dose-dependent induction of recessive mutations with N-ethyl-N-nitrosourea in primordial germ cells of male mice.

Mutation research·1996
Same author

Inducible osteonecrosis in a rabbit serum sickness model: deposition of immune complexes in bone marrow.

Bone·1996
Same author

Cytomegalovirus-induced interstitial pneumonitis in a patient with systemic lupus erythematosus.

Internal medicine (Tokyo, Japan)·1996
Same author

Hemostasis activation during sclerotherapy of lower extremity varices.

Thrombosis research·1996
Same author

[A case of schistosomiasis suspected by circumoval precipitin test and diagnosed by rectal biopsy].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases·1996

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epileptology

Background:

  • Epilepsy treatment relies on antiepileptic drugs (AEDs) with varying mechanisms and spectra of action.
  • Zonisamide (1,2-benzisoxazole-3-methanesulfonamide, ZNS) is an experimental AED.
  • Understanding ZNS's effects on neuronal mechanisms is crucial for predicting its clinical utility.

Purpose of the Study:

  • To compare the effects of zonisamide (ZNS) on the trigeminal complex with established antiepileptic drugs.
  • To elucidate the neurophysiological mechanisms underlying ZNS's anticonvulsant activity.
  • To predict the clinical spectrum of ZNS based on its effects in an experimental model.

Main Methods:

  • Intravenous administration of zonisamide (ZNS) at doses of 10-40 mg/kg in cats.

Related Experiment Videos

  • Assessment of ZNS's effects on descending excitatory and inhibitory mechanisms within the trigeminal complex.
  • Comparison of ZNS's neurophysiological profile with those of valproate, carbamazepine (CBZ), and phenytoin.

    • Main Results:

    • Zonisamide (ZNS) significantly depressed descending excitatory and segmental/descending inhibitory mechanisms.
    • ZNS had a minor effect on segmental excitatory mechanisms.
    • The observed spectrum of activity for ZNS was comparable to valproate and suggested broad-spectrum efficacy, aligning with its effectiveness against complex partial, generalized tonic-clonic, and myoclonic seizures.

    Conclusions:

    • Zonisamide's (ZNS) neurophysiological effects in cats suggest it is a broad-spectrum antiepileptic drug.
    • The experimental model provides a more accurate prediction of ZNS's clinical spectrum compared to conventional screening tests.
    • ZNS's mechanism of action contributes to its efficacy across diverse seizure types.